Related Experiment Video
Updated: Jul 11, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Biological effects of oxysterols on platelet function
Thrombosis Research
|April 1, 1988
Summary
Different oxysterols modulate platelet aggregation and serotonin secretion. Some oxysterols inhibit these functions, while others potentiate them, offering new insights into sterol roles in cell membrane function and pathology.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Oxysterols are cholesterol oxidation products implicated in various pathologies.
- Platelets play a crucial role in hemostasis and thrombosis.
- The specific effects of different oxysterols on platelet function remain incompletely understood.
Purpose of the Study:
- To investigate the in vitro effects of various oxysterols on isolated rat platelet aggregation and serotonin secretion.
- To determine whether oxysterols act as inhibitors or potentiators of platelet activation.
Main Methods:
- Isolated rat platelets were exposed to different oxysterols (1-20 uM) in vitro.
- Platelet aggregation was measured using turbidimetry following stimulation with thrombin or adenosine diphosphate (ADP).
- Serotonin secretion was quantified using voltammetry after thrombin stimulation.
Main Results:
- Oxysterols exhibited differential effects on platelet function.
- 7B-hydroxy cholesterol showed no significant effect on platelet aggregation or secretion.
- 22S-hydroxy cholesterol and 3,5,6-hydroxy cholestan triol potentiated platelet responses.
- 25-hydroxy cholesterol and 7-oxo cholesterol inhibited platelet aggregation and serotonin secretion.
Conclusions:
- In vitro incubation with specific oxysterols modulates rat platelet behavior.
- Certain oxysterol derivatives act as inhibitors, while others function as potentiators of platelet activity.
- These findings contribute to understanding the role of oxysterols in cell membrane structure and function, with implications for pathological conditions.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...